Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Blier

Showing results (171-180 of 229) with videos related to

Pageof 23
Sort By:
Neuropsychopharmacology Reports|December 4, 2024
Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptomsAndrew Krystal, Pierre Blier, Larry Culpepper, et al.
Neuroreport|August 2, 2002
Neurokinin-1 receptors are decreased in major depressive disorderCraig A Stockmeier, Xiaochun Shi, Lisa Konick, et al.
Archives of General Psychiatry|June 9, 2004
Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depressionPedro Rosa-Neto, Mirko Diksic, Hidehiko Okazawa, et al.
The International Journal of Neuropsychopharmacology|October 13, 2017
Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual PatientOloruntoba J Oluboka, Martin A Katzman, Jeffrey Habert, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 25, 2012
Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatryKonstantinos N Fountoulakis, Siegfried Kasper, Ole Andreassen, et al.
Clinical EEG and Neuroscience|June 3, 2021
Depression Diagnosis Modeling With Advanced Computational Methods: Frequency-Domain eMVAR and Deep LearningCaglar Uyulan, Sara de la Salle, Turker T Erguzel, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 4, 2015
A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based NomenclatureJoseph Zohar, Stephen Stahl, Hans-Jurgen Moller, et al.
Communications Medicine|March 24, 2026
Deep learning using electroencephalogram (EEG) data for diagnosing and predicting SSRI response in major depressive disorderSebastian Olbrich, Natalia Jaworska, Sara de la Salle, et al.
The International Journal of Neuropsychopharmacology|December 6, 2019
The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar DisorderKonstantinos N Fountoulakis, Lakshmi N Yatham, Heinz Grunze, et al.
The International Journal of Neuropsychopharmacology|August 5, 2022
Assessment of Objective and Subjective Cognitive Function in Patients With Treatment-Resistant Depression Undergoing Repeated Ketamine InfusionsJennifer L Phillips, Amanda Van Geel, Patricia Burhunduli, et al.
Pageof 23

Showing results (171-180 of 229) with videos related to

Sort By:
Pageof 23
Neuropsychopharmacology Reports|December 4, 2024
Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptomsAndrew Krystal, Pierre Blier, Larry Culpepper, et al.
Neuroreport|August 2, 2002
Neurokinin-1 receptors are decreased in major depressive disorderCraig A Stockmeier, Xiaochun Shi, Lisa Konick, et al.
Archives of General Psychiatry|June 9, 2004
Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depressionPedro Rosa-Neto, Mirko Diksic, Hidehiko Okazawa, et al.
The International Journal of Neuropsychopharmacology|October 13, 2017
Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual PatientOloruntoba J Oluboka, Martin A Katzman, Jeffrey Habert, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 25, 2012
Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatryKonstantinos N Fountoulakis, Siegfried Kasper, Ole Andreassen, et al.
Clinical EEG and Neuroscience|June 3, 2021
Depression Diagnosis Modeling With Advanced Computational Methods: Frequency-Domain eMVAR and Deep LearningCaglar Uyulan, Sara de la Salle, Turker T Erguzel, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 4, 2015
A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based NomenclatureJoseph Zohar, Stephen Stahl, Hans-Jurgen Moller, et al.
Communications Medicine|March 24, 2026
Deep learning using electroencephalogram (EEG) data for diagnosing and predicting SSRI response in major depressive disorderSebastian Olbrich, Natalia Jaworska, Sara de la Salle, et al.
The International Journal of Neuropsychopharmacology|December 6, 2019
The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar DisorderKonstantinos N Fountoulakis, Lakshmi N Yatham, Heinz Grunze, et al.
The International Journal of Neuropsychopharmacology|August 5, 2022
Assessment of Objective and Subjective Cognitive Function in Patients With Treatment-Resistant Depression Undergoing Repeated Ketamine InfusionsJennifer L Phillips, Amanda Van Geel, Patricia Burhunduli, et al.
Pageof 23